Arterial Calcification Due to Deficiency of CD73 (ACDC) As One of Rheumatic Diseases Associated With Periarticular Calcification

Authors:
  • ATAtsuo Taniguchi
    Atsuo Taniguchi
  • HKHirotaka Kaneko
    Hirotaka Kaneko
  • MKManabu Kawamoto
    Manabu Kawamoto
  • CSChieko Sekita
    Chieko Sekita
  • ANAyako Nakajima
    Ayako Nakajima
  • HYHisashi Yamanaka
    Hisashi Yamanaka

Abstract
In 2011, St Hilaire et al (N Engl J Med. 2011;364:432-442) identified mutations in the ecto-5'-nucleotidase (NT5E) gene, which encodes CD73, in members of 3 families with symptomatic arterial and joint calcifications. The deficiency of CD73 involves the extracellular adenosine metabolism that influences inorganic pyrophosphate and phosphate metabolism and leads to tissue calcification. Herein, we report an additional case with arterial calcification due to deficiency of CD73. Genetic analyses revealed that the patient was a compound heterozygote of mutations in the NT5E gene. The present case had intermittent monoarthritis of the finger joints and early-onset osteoarthritis in the hands. Occlusion of calcified peripheral arteries is the most important outcome of the disease. However, the rheumatic manifestations may be important clues to the diagnosis. Rheumatologists should recognize deficiency of CD73 as a rheumatic disease.

This publication has 10 references indexed in Scilit: